Hereditary spherocytosis is a well‐recognised genetic disorder affecting red blood cell membrane stability, resulting in the formation of spherocytes—cells that are less deformable and prone to ...

Medically reviewed by Benjamin Leach, MD Key Takeaways Spherocytosis is a blood disorder that makes red blood cells sphere-shaped, leading to anemia and other issues.Treatments include folic acid ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency.

A new drug that is both the first in its class and the first disease-modifying agent for hemolytic anemia in adults with pyruvate kinase (PK) deficiency has been approved by the US Food and Drug ...

An oral pyruvate kinase (PK) activator, mitapivat becomes the only approved option for treating anemia in both ...

The FDA has approved Pyrukynd (mitapivat) for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency. The Food and Drug Administration (FDA) has approved Pyrukynd ® (mitapivat) ...

Iron deficiency anemia occurs when there are insufficient red blood cells due to a lack of iron. In some cases, iron deficiency anemia can be genetic, as people can pass genetic variations onto their ...

Anemia poses a significant public health challenge, primarily impacting the health of young children, pregnant and postpartum women, as well as menstruating adolescent girls and adult women. On a ...

Warm hemolytic anemia is a rare condition that affects your red blood cells. It causes anemia-like symptoms, such as fatigue, jaundice, and paleness. Share on Pinterest ZeynepKaya/Getty Images In warm ...

The biopharmaceutical company said Tuesday that Aqvesme is now the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia.